Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.